Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A pharmacogenetic study of polymorphisms in interferon pathway genes and response to interferon-alpha treatment in chronic hepatitis B patients.

Antiviral research - 1 Sept 2009

Wu Xiaopan, Zhu Xilin, Zhu Shuying, Li Jingyun, Ma Juan, Li Zhuo, Li Hui, Liu Ying

Abstract excerpt

Certain host genetic polymorphisms in interferon (IFN) signaling pathway genes are reported to be associated with response to IFNalpha therapy. We studied 10 single nucleotide polymorphisms (SNPs) in IFN signaling pathway genes to examine their associations with response to IFN treatment in chronic hepatitis B (CHB) patients. Two hundred and forty-six IFNalpha treatment-naïve CHB patients were enrolled for the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 2',5'-Oligoadenylate Synthetase
Share to DNA Fingerprinting

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, MHC Class II

Share to Haplotypes

Share to Hepatitis B, Chronic

Share to Interferon-alpha

Share to Polymorphism, Restriction Fragment Length

Share to Treatment Outcome

Source

Identifiers

PMID: 19559055
DOI: 10.1016/j.antiviral.2009.06.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A pharmacogenetic study of polymorphisms in interferon pathway genes and response to interferon-alpha treatment in chronic hepatitis B patients.PMID 19559055Read ↗

Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot studySemantic proximity Read ↗

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.Semantic proximity Read ↗

Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot studySemantic proximity Read ↗

Polymorphisms of interferon-inducible genes OAS associated with interferon-α treatment response in chronic HBV infection.Semantic proximity Read ↗

Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.Semantic proximity Read ↗

Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis C.Semantic proximity Read ↗

Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR.Semantic proximity Read ↗

An interferon response gene signature is associated with the therapeutic response of hepatitis C patients.Semantic proximity Read ↗

Genetic predisposition of responsiveness to therapy for chronic hepatitis C.Semantic proximity Read ↗

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy.Semantic proximity Read ↗

A polymorphism in MAPKAPK3 affects response to interferon therapy for chronic hepatitis C.Semantic proximity Read ↗

JAK1 gene polymorphisms are associated with the outcomes of hepatitis B virus infection, but not with α interferon therapy response in a Han Chinese population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.